Skip to Main Content
ManagedCareEye.com
This website is supported by an independent medical education grant from Regeneron Pharmaceuticals, Inc.
  • Home
  • CE Activities
  • Faculty
  • Expert Updates
  • Outcomes
  • Resources

Assessing Variation in Payer Coverage of Anti-VEGF Therapies for Retinal Diseases

April 10, 2025
← Assessing Variation in Payer Coverage of Anti-VEGF Therapies for Retinal Diseases   Virtual Journal Club: Best Practices in Payer Coverage and Utilization Management of Anti-VEGF Therapies for AMD and DR/DME →
  • About Impact Education, LLC
  • Contact Us (IMPACT)
  • Mailing List (IMPACT)
  • Privacy Policy

Jointly provided by

Medical Education Resources Impact Education, LLC

Supported by an independent medical education grant from Regeneron Pharmaceuticals, Inc.

NEW Publication

Assessing Variation in Payer Coverage of Anti-VEGF Therapies for Retinal Diseases

Read Now